Evidence for opioid receptor interactions in vivo
Heyman, J.S.; Porreca, F.
Proceedings of the Western Pharmacology Society 31: 287-289
1988
ISSN/ISBN: 0083-8969 PMID: 2850560 Document Number: 322981
Document emailed within 1 workday
Related Documents
Schoffelmeer, A.N.; Yao, Y.H.; Gioannini, T.L.; Hiller, J.M.; Ofri, D.; Roques, B.P.; Simon, E.J. 1990: Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex Journal of Pharmacology and Experimental Therapeutics 253(1): 419-426Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Fang, L.; Knapp, R.J.; Horvath, R.; Matsunaga, T.O.; Haaseth, R.C.; Hruby, V.J.; Porreca, F.; Yamamura, H.I. 1994: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity Journal of Pharmacology and Experimental Therapeutics 268(2): 836-846
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Garzón, J.; de Antonio, I.; Sánchez-Blázquez, P. 2000: In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides Methods in Enzymology 314: 3-20
Garzón, J.; Sánchez-Blázquez, P.; Lee, N.M. 1984: 3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type Journal of Pharmacology and Experimental Therapeutics 231(1): 33-37
Horan, P.; de Costa, B.R.; Rice, K.C.; Porreca, F. 1991: Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice Journal of Pharmacology and Experimental Therapeutics 257(3): 1154-1161
Zimmerman, D.M.; Leander, J.D.; Reel, J.K.; Hynes, M.D. 1987: Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands Journal of Pharmacology and Experimental Therapeutics 241(2): 374-378
Maggi, C.A.; Giuliani, S.; Ballati, L.; Lecci, A.; Manzini, S.; Patacchini, R.; Renzetti, A.R.; Rovero, P.; Quartara, L.; Giachetti, A. 1991: In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376 Journal of Pharmacology and Experimental Therapeutics 257(3): 1172-1178
Ray, S.B.; Gupta, Y.K.; Wadhwa, S. 2005: Expression of opioid receptor-like 1 (ORL1) and mu opioid receptors in the spinal cord of morphine tolerant mice Indian Journal of Medical Research 121(3): 194-202
Rao, T.S.; Cler, J.A.; Emmett, M.R.; Mick, S.; Iyengar, S.; Wood, P.L. 1990: BMY-14802 antagonizes harmaline- and D-serine-induced increases in mouse cerebellar cyclic GMP: neurochemical evidence for a sigma receptor-mediated functional modulation of responses mediated by the N-methyl-D-aspartate receptor complex in vivo Molecular Pharmacology 37(6): 978-982
Cserpán, E.; Tryoen-Tóth, P.; Bajenaru, L.; Benyhe, S.; Maderspach, K. 1997: Differential expression of the K-2 opioid receptor protein under the effect of opioid agonists in embryonic chick neurons in vitro Neurobiology 5(2): 233-248
Mosberg, H.I.; Heyl, D.L.; Haaseth, R.C.; Omnaas, J.R.; Medzihradsky, F.; Smith, C.B. 1990: Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity Molecular Pharmacology 38(6): 924-928
Jiang, Q.; Takemori, A.E.; Sultana, M.; Portoghese, P.S.; Bowen, W.D.; Mosberg, H.I.; Porreca, F. 1991: Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(3): 1069-1075
Parsons, C.G.; Herz, A. 1990: Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress Journal of Pharmacology and Experimental Therapeutics 255(2): 795-802
Wong, C.S.; Su, Y.F.; Watkins, W.D.; Chang, K.J. 1992: Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes Journal of Pharmacology and Experimental Therapeutics 262(1): 317-326
Yung, L.Y.; Joshi, S.A.; Chan, R.Y.; Chan, J.S.; Pei, G.; Wong, Y.H. 1999: GalphaL1 (Galpha14) couples the opioid receptor-like1 receptor to stimulation of phospholipase C Journal of Pharmacology and Experimental Therapeutics 288(1): 232-238
Rong, S.B.; Zhu, Y.C.; Jiang, H.L.; Zhao, S.R.; Wang, Q.M.; Chi, Z.Q.; Chen, K.X.; Ji, R.Y. 1997: Molecular modeling of mu opioid receptor and receptor-ligand interaction Zhongguo Yao Li Xue Bao 18(4): 317-322
van Vliet, B.J.; Mulder, A.H.; Schoffelmeer, A.N. 1990: Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons Progress in Clinical and Biological Research 328: 409-412
Rónai, A.Z.; Botyánszki, J.; Magyar, A.; Borsodi, A.; Benyhe, S.; Medzihradszky, K. 1993: Novel, delta-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site Archives Internationales de Pharmacodynamie et de Therapie 323: 114-125